Safety evaluation of oral administration of An’erning granules in young rats
Author:
Affiliation:

1. Center of Safety Evaluation, Hangzhou Medical College, Hangzhou 310053, China. 2. Key Laboratory of Drug Safety Evaluation and Research of Zhejiang Province, Hangzhou Medical College, Hangzhou 310053. 3. Arura Tibetan Medicine (Shandong) Health Industry Co. , Ltd, Jinan 250104

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To study the toxicity of a single administration and 3-month repeated administration of An’ erning (AEN) granules in juvenile SD rats, and evaluate the long-term safety in children. Methods 20 juvenile SD rats (3 ~ 4 weeks) were given the maximum administration dosage ( 240 g crude drug / kg). This was followed by an observation of toxicity reactions and death for 15 days. Juvenile SD rats (200) were divided into vehicle control, Aconitum tanguticum control, low-dose, middle-dose, and high-dose groups. Each group was composed of 40 rats ( half male and half female), each of which was given purified water, A. tanguticum (5. 5 g crude drug / kg), and AEN (3, 11, and 40 g crude drug / kg), all in a volume of 10 mL/ kg, for 91 days. Food intake and body weight were measured, and hematology, biochemistry, coagulation, urine, ophthalmologic, and histopathology examinations of 5,10 and 5 rats for each sex in each group were conducted mid-administration, upon drug withdrawal, and 4 weeks after withdrawal. Results No obvious toxic effects or deaths were recorded after the single administration of AEN. After the 3-month repeated administration of AEN, male rats in the high-dose group had decreased body weights, decreased food intake, reversibly increased NEUT count, NEUT ratio, MONO count, MONO ratio, and ALB, and reversibly decreased AST, Na+ , and Cl- . Conclusions There were no obvious toxicity reactions in young rats given AEN granules. The relative safe dosage of AEN was 40 g crude drug / kg, and the no observed adverse effect level (NOAEL ) is 11 g crude drug / kg. The clinical administration of AEN is safe.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 02,2022
  • Revised:
  • Adopted:
  • Online: March 24,2023
  • Published: